Agios Pharmaceuticals (AGIO) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -4.81 | -4.89 | -4.17 | -4.77 | -4.18 | -4.30 | |||
| Changes by years, y/y, % | -51% | +2% | -15% | +14% | -12% | -15.7% | |||
Agios Pharmaceuticals. P/FCF
Agios Pharmaceuticals. P/FCF, changes, %
Agios Pharmaceuticals (AGIO) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | -4.17 | -4.71 | -5.64 | -4.21 | -5.17 | -4.30 | ||
| Changes by years, y/y, % | -24% | -41% | -26% | -12% | +24% | |||
| Changes by quarters, q/q, % | -13% | +13% | +20% | -25% | +23% | |||